Puradelta Lestari Tbk PT
IDX:DMAS
Puradelta Lestari Tbk PT
IDX:DMAS
Price:
148
IDR
Market Closed
Market Cap:
7.1T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
DMAS Alert
Puradelta Lestari Tbk PT
148
0 (0%)
| 52 Week Range |
146
173
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Puradelta Lestari Tbk PT
Balance Sheet
Balance Sheet Decomposition
Puradelta Lestari Tbk PT
Puradelta Lestari Tbk PT
| Current Assets | 5.5T |
| Cash & Short-Term Investments | 1.9T |
| Receivables | 4.7B |
| Other Current Assets | 3.6T |
| Non-Current Assets | 2.2T |
| Long-Term Investments | 343B |
| PP&E | 433.2B |
| Other Non-Current Assets | 1.5T |
| Current Liabilities | 667.8B |
| Accounts Payable | 50.3B |
| Accrued Liabilities | 2B |
| Other Current Liabilities | 615.6B |
| Non-Current Liabilities | 74.4B |
| Other Non-Current Liabilities | 74.4B |
Balance Sheet
Puradelta Lestari Tbk PT
Puradelta Lestari Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
306 144
|
243 444
|
227 920
|
160 063
|
95 967
|
104 497
|
87 663
|
691 662
|
763 368
|
1 027 412
|
|
| Cash |
306 144
|
243 444
|
227 920
|
160 063
|
95 967
|
104 497
|
87 663
|
198 820
|
104 210
|
146 288
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
492 842
|
659 158
|
881 124
|
|
| Short-Term Investments |
1 075 411
|
931 736
|
991 785
|
626 083
|
649 705
|
563 111
|
1 288 462
|
709
|
709
|
622
|
|
| Total Receivables |
0
|
0
|
0
|
49 818
|
82 748
|
1 090 422
|
39 221
|
12
|
130 374
|
459
|
|
| Accounts Receivables |
0
|
0
|
0
|
49 818
|
82 748
|
1 090 422
|
39 221
|
0
|
130 019
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
354
|
0
|
|
| Inventory |
2 236 256
|
2 427 526
|
2 379 892
|
2 601 937
|
2 679 078
|
2 175 573
|
2 079 427
|
2 282 767
|
2 668 816
|
3 066 890
|
|
| Other Current Assets |
48 965
|
892 469
|
114 240
|
97 927
|
60 121
|
75 582
|
247 158
|
282 965
|
234 665
|
247 191
|
|
| Total Current Assets |
3 666 775
|
4 495 175
|
3 713 837
|
3 535 828
|
3 567 620
|
4 009 185
|
3 741 930
|
3 165 390
|
3 797 720
|
4 341 846
|
|
| PP&E Net |
133 651
|
183 362
|
305 374
|
319 502
|
312 803
|
309 630
|
291 978
|
309 679
|
378 580
|
404 762
|
|
| PP&E Gross |
133 651
|
183 362
|
305 374
|
319 502
|
312 803
|
309 630
|
291 978
|
309 679
|
378 580
|
404 762
|
|
| Accumulated Depreciation |
21 389
|
25 218
|
34 543
|
53 693
|
72 672
|
94 685
|
117 224
|
140 123
|
159 892
|
187 314
|
|
| Note Receivable |
0
|
0
|
0
|
14 827
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
9 985
|
18 957
|
29 796
|
83 693
|
208 150
|
244 180
|
236 686
|
248 763
|
441 457
|
347 569
|
|
| Other Long-Term Assets |
3 792 416
|
3 309 627
|
3 754 845
|
3 517 092
|
3 411 461
|
3 053 976
|
2 481 639
|
2 390 109
|
2 005 657
|
1 624 331
|
|
| Total Assets |
7 602 827
N/A
|
8 007 121
+5%
|
7 803 852
-3%
|
7 470 942
-4%
|
7 500 033
+0%
|
7 616 971
+2%
|
6 752 233
-11%
|
6 113 942
-9%
|
6 623 414
+8%
|
6 718 508
+1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
4 610
|
53 562
|
39 345
|
18 364
|
2 099
|
31 093
|
9 743
|
31 346
|
10 711
|
27 957
|
|
| Accrued Liabilities |
521
|
5 276
|
17 962
|
18 999
|
6 572
|
41 192
|
1 630
|
413
|
1 448
|
3 871
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
655
|
703
|
0
|
566
|
|
| Other Current Liabilities |
596 992
|
770 557
|
338 102
|
400 439
|
270 735
|
1 007 996
|
1 154 950
|
667 950
|
776 487
|
695 315
|
|
| Total Current Liabilities |
909 293
|
829 395
|
395 409
|
437 802
|
279 406
|
1 080 281
|
1 166 978
|
700 412
|
788 646
|
727 710
|
|
| Long-Term Debt |
286 213
|
0
|
0
|
0
|
0
|
0
|
703
|
0
|
0
|
532
|
|
| Minority Interest |
2 773
|
3 054
|
3 364
|
3 764
|
3 509
|
3 406
|
3 537
|
2 994
|
3 165
|
3 304
|
|
| Other Liabilities |
11 945
|
17 128
|
20 058
|
27 302
|
32 124
|
40 951
|
56 494
|
62 356
|
110 120
|
109 873
|
|
| Total Liabilities |
1 210 224
N/A
|
849 577
-30%
|
418 831
-51%
|
468 868
+12%
|
315 039
-33%
|
1 124 637
+257%
|
1 227 713
+9%
|
765 763
-38%
|
901 931
+18%
|
841 419
-7%
|
|
| Equity | |||||||||||
| Common Stock |
4 337 830
|
4 819 811
|
4 819 811
|
4 819 811
|
4 819 811
|
4 819 811
|
4 819 811
|
4 819 811
|
4 819 811
|
4 819 811
|
|
| Retained Earnings |
2 170 868
|
1 958 003
|
2 185 480
|
1 802 532
|
1 985 453
|
1 292 792
|
324 979
|
148 637
|
521 942
|
677 548
|
|
| Additional Paid In Capital |
116 095
|
379 730
|
379 730
|
379 730
|
379 730
|
379 730
|
379 730
|
379 730
|
379 730
|
379 730
|
|
| Total Equity |
6 392 603
N/A
|
7 157 544
+12%
|
7 385 021
+3%
|
7 002 074
-5%
|
7 184 995
+3%
|
6 492 334
-10%
|
5 524 520
-15%
|
5 348 179
-3%
|
5 721 483
+7%
|
5 877 090
+3%
|
|
| Total Liabilities & Equity |
7 602 827
N/A
|
8 007 121
+5%
|
7 803 852
-3%
|
7 470 942
-4%
|
7 500 033
+0%
|
7 616 971
+2%
|
6 752 233
-11%
|
6 113 942
-9%
|
6 623 414
+8%
|
6 718 508
+1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
43 378
|
48 198
|
48 198
|
48 198
|
48 198
|
48 198
|
48 198
|
48 198
|
48 198
|
48 198
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
